Latest filing published 10 Jul 2024 for LIFECORE BIOMEDICAL, INC. \DE\.
Insider track record
No signal scores available.
Nathaniel Calloway: trading record in brief
This profile gathers the share dealings of Nathaniel Calloway in Lifecore Biomedical, Inc. \DE\. Over a trading history stretching from 1 June 2023 to 8 July 2024, the count stands at 4 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 10 July 2024 came the latest disclosure, a share grant in Lifecore Biomedical, Inc. \DE\. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Nathaniel Calloway
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,000 sharesCommon StockSEC:0001628280-24-031634:0
- 3,981 sharesCommon StockSEC:0001628280-24-003139:0
- 5,906 sharesCommon StockSEC:0001628280-24-001074:0
- 18,182 sharesCommon StockSEC:0001628280-23-020835:0
4 of 4 declarations
